The public health risk and economic impact of dampness and mold exposures was assessed using current asthma as a health endpoint. Individual risk of current asthma from exposure to dampness and mold in homes from Fisk et al. (2007) , and asthma risks calculated from additional studies that reported the prevalence of dampness and mold in homes were used to estimate the proportion of U.S. current asthma cases that are attributable to dampness and mold exposure at 21% (95% confidence internal 12-
INTRODUCTION
There is a rapidly growing body of scientific literature examining the relationship between dampness and mold in buildings and associated health effects. Reviews by expert groups in Europe (Bornehag et al. 2001; Bornehag et al. 2004 ) and the United States (IOM, 2004 ) draw similar conclusions:
• There is sufficient scientific evidence to conclude that there is an association between dampness and mold in buildings and an increased risk of adverse health effects for building occupants.
• The most common health effects appear to be associated with the respiratory system, although a much broader array of health outcomes has been reported.
In the United States, the growing scientific consensus on this issue has been accompanied by substantial public concern. This is evidenced by a rapid escalation in the number of mold claims against builders and their insurance companies, a growing tendency for insurance companies to drop mold coverage from their insurance policies, and the rapid growth in mold litigation and mold remediation expenditures (Levin, 2005; Prahl, 2002) .
In light of new information that is accumulating on moisture and mold, and in recognition of growing public concern about these issues, this paper estimates the magnitude of public health risk and its associated economic impact. This will aid policy makers as they review current national measures to control moisture and mold in the built environment.
MAGNITUDE OF THE PUBLIC HEALTH RISK
To assess the magnitude of the public health risk from dampness and mold, we estimated the number of cases of current asthma attributable to dampness and mold exposure in U. S. homes. Current asthma is defined as doctor diagnosed asthma with symptoms or medication used in the past 12 months. While other health effects are also associated with dampness and mold, the lack of available data limits our assessments to asthma alone. The estimate is derived from data on increased individual risk associated with exposure to dampness and mold, and the prevalence of dampness and mold in U.S. homes. Evidence of health effects associated with exposures in offices and schools is presented in the appendix.
Increased risk associated with exposure to dampness and mold in housing
The scientific consensus of an increased health risk from dampness and mold 1 in buildings does not extend to quantification of that risk. However, in a companion paper in this journal (Fisk, et al., 2007 ) the authors estimate that exposure to dampness and mold raises the risk for various adverse respiratory outcomes by 30-50%. These estimates indicate a very substantial increase in risk for individuals exposed to dampness and mold in their homes. The estimates were derived from a meta analysis of 33 peer reviewed studies. Table 1 presents a summary of key results from the Fisk et al. (2007) meta analysis. The odds ratios in Table 1 are interpreted by the authors to reflect increases in relative risk of 30-50%. The evidence of higher individual risk does not specifically address the primary causal agents responsible for the reported health outcomes. No one expects, for example, that dampness per se is a causal agent, but dampness (or moisture) is known to promote the growth and proliferation of dust mites, mold, and bacteria, exposure to which can result in allergic or infectious health outcomes. In addition, dampness promotes the degradation of some building materials and furnishings and can increase and/or alter their emissions. Whatever the primary causal agents, policies and programs that are successful in preventing and mitigating dampness and mold conditions would also be effective in reducing the public health risks and associated economic impacts.
Prevalence of dampness and mold exposure
The magnitude of the public health impact of dampness and mold also depends on the prevalence of dampness and mold. The American Housing Survey of the U.S. Census for 2003 reports that 10.4% of U.S. homes had water damage from exterior leakage, while 8% had water damage from interior leakage. However, the survey did not cover dampness or mold. There is otherwise no national database on the prevalence of dampness and mold in U.S. houses; however, Table 2 compiles data from studies that reported prevalence of various moisture related conditions in U.S. houses.
There is considerable variation in the prevalence estimates for each of the indicated moisture categories. For the "any dampness or mold category", four of the studies report the prevalence to be 50% or more, while three report prevalence values below 50%. The largest study (Spengler, 1994) reports prevalence of dampness and mold in 50% of the homes. Excluding the Freeman study because it only included bathrooms, the population weighted average prevalence of dampness or mold from these studies is 47% in the U.S. The fraction of those current asthma cases attributable to dampness and mold exposure can be calculated using equation 1.
where AF is the attributable fraction, P is the prevalence of the risk factor (e.g. dampness and mold ), and RR is the relative risk of exposure (e.g.. the ratio of the risk in the exposed population relative to the unexposed population.) The meta-analyses by Fisk et al., (2007) found that the odds ratio for current asthma in homes with dampness and mold was 1.56 (95% confidence interval: 1.3 to 1.86). The odds ratio is a close approximation of the relative risk when the prevalence of the health outcome is low (e.g. under 15%). Asthma prevalence is approximately 7% .Using the odds ratio of 1.56 as an approximation of the relative risk, and a 47% prevalence for dampness and mold, the central estimate for the fraction of current asthma cases attributable to dampness and mold exposure in housing is estimated to be 21% with an upper and lower confidence interval representing attributable fractions of 12% and 29% respectively.
Thus, out of the 21.8 million people reported to have asthma in the U.S., approximately 4.6 (2.7 to 6.3) million cases are estimated to be attributable to dampness and mold exposure in the home. This represents a substantial public health impact that could potentially be avoided with appropriate policies and programs designed to prevent or mitigate dampness and mold in the home. (Weiss et al. 2001 and Smith et al. 1997) . Weiss et al., and Smith et al. estimated costs in 1998 and 1994 respectively. The costs from these studies were updated to 2004 by adjusting for population growth, inflation, and an increase in asthma prevalence. A medical cost inflator was used to update morbidity cost estimates, while a general inflator was used to update the mortality and indirect cost estimates using data from Table 706 of U.S. Census Bureau (2006) . The adjustment for asthma prevalence was less straight forward because prevalence data were not available for 1994, the year for which Smith et al. (1997) provided estimates. A prevalence estimate for that year was therefore interpolated based on an annual average increment of prevalence between 1980 and 1996 (Mannino et al., 2002) . In addition, the mortality estimate of Weiss et al. (2001) was adjusted downward to account for reduced mortality of asthmatics since 1998 2 . The estimates of morbidity (i.e., medical) costs from the two studies are similar; however medical costs are represented by actual medical expenditures, which in turn are influenced by access to medical care and may therefore underestimate the full national cost. The estimate of indirect cost based on Weiss et al. (2001) is much higher than the estimate based on Smith et al. (1997) . Only Weiss included an estimate for mortality costs.
MAGNITUDE OF THE ECONOMIC IMPACT
The selected cost estimate for this paper includes the adjusted Weiss et al. (2001) estimate for mortality, and an average of both adjusted estimates for the morbidity and indirect costs. Accordingly, for the purpose of this analysis, the total cost of asthma in the U.S. for 2004 is estimated to be approximately $17 billion dollars a year. Table 3 also presents an estimate of the annual costs of asthma attributable to building dampness and mold. The attributable cost is calculated by multiplying the selected estimate of costs by the attributable fraction of 21% (CI interval of 12%-29%). The total annual asthma cost attributable to exposure to dampness and mold in homes is estimated to be approximately $3.5 billion.
Thus, there is an economic consequence from dampness and mold due to asthma alone that is in the range of billions of dollars per year. This should be significant enough to justify a significant community response. The cost of other health endpoints beside asthma along with the cost of building damage caused by dampness and mold add further justification. 
EVIDENCE OF RISK IN SCHOOLS, OFFICES, AND INSTITUTIONAL BUILDINGS
While the above population risk and economic impact estimates are limited to homes, evidence suggests that health risks in other buildings are also likely to be substantial. This conclusion is supported by research on the relationship between dampness and mold and health outcomes in schools, offices, and institutional buildings. While this research is not nearly as extensive as it is for housing, the evidence clearly points toward similar conclusions. Table A1 and Table A2 in the Appendix compile the characteristics and key findings of research on the relationship between dampness or mold and occupant health in schools (Table A1 ) and offices and institutional buildings (Table A2 ). Papers published in refereed archival journals were identified from a computerized bibliographic search using the Pubmed bibliographic search system. The tables includes all relevant studies, whether or not the study found dampness or mold to increase the risk of health effects. However, only papers that included at least one respiratory or asthma related health outcome are listed in the tables, though most studies examined a variety of other health outcomes. Purely descriptive (non-analytic) case studies of mold problems in buildings were not reviewed.
14 studies of schools and 8 studies of offices and institutional buildings were reviewed. The studies measured a variety of risk factors and employed a variety of study designs. For schools (Table A1) , the major risk factor for 5 studies was microbial concentrations in the air or in dust on floors, or visible/odorous signs of mold. (Ebbhoj et al. 2005; Meyer et al. 2003 Meyer et al. , 2005 Park et al. 2004; Rylander et al. 1998; Smedje et al 1997; ) . The major risk factor for the remaining 9 studies was dampness or mold in buildings at large. Most studies employed a stratified cross sectional design, which compared health outcomes among occupants of damp or moldy schools to health outcomes among occupants of reference dry schools. Most studies in schools controlled for a fairly broad range of potential confounding factors.
Risk factors in offices and institutional buildings (Table A2 ) included microbial concentrations in the air or in chair or floor dust (Chao et al. 2003; Park et al. 2006; , dampness in the building at large (Cox-Ganser et al. 2005 ; or poor cooling coil drain pan drainage in the HVAC system ( Mendell et al 2003) . One study (Menzies et al. 2003) was an intervention study using ultraviolet germicidal irradiation of cooling coils in the HVAC that showed a reduction in risk from the intervention. The studies employed a variety of study designs. Several studies were cross sectional across multiple buildings (Chao et al. 2003; Wan et al. , 1999b Mendell et al. 2003) , or multiple spaces within a building (Park et al. 2006) . Two studies (CoxGanser et al. 2005, and Menzies et al. 1998 ) employed a case control design based on health symptoms. Finally, one study (Menzies et al. 2003 ) was a blinded crossover intervention study.
As with the school studies, most studies for offices and institutional buildings controlled for numerous potential confounding factors.
The evidence supporting an association of dampness or mold in offices and institutional buildings with respiratory or other health effects of occupants is reasonably robust. Every study identified found one or more statistically significant association between dampness or mold and adverse respiratory or other health effects. In many cases, the magnitude of the increased risk of health effects in damp or moldy buildings was appreciable, e.g., greater than 100%. The health outcomes found to increase with dampness and mold, (e.g. lower respiratory symptoms typical of asthma, mucous membrane symptoms, headache, and fatigue) are the same as those found to be associated with dampness and mold in housing.
There are, of course, uncertainties in the results. Tables A1 and A2 only identify those findings that were statistically significant. Most studies failed to find associations between some risk factors and several of the adverse health effects assessed. However, given the crude measurement methods currently available in this field of research, and the multiple risk factors and health outcomes investigated, some failures to find an association would be expected even if there were true underlying causal relationships. On the other hand, since the studies performed numerous statistical tests, some of the positive associations found may be the result of chance. Finally, publication bias (i.e. less frequent publication of findings that do not conform to expectations) increases the likelihood that published studies would report positive findings.
Overall, there is good reason to believe that the results found in offices and institutional buildings reflect an underlying causal relationship between dampness and mold exposures and the reported health outcomes. There were a large number of significant associations between dampness and mold and adverse health; the increased health risk in some studies was quite large; there were no statistically significant inverse findings of improved health with dampness or mold; and the findings are consistent with the findings from the much larger body of research performed in homes 3 .
Studies in schools also show significant health risks from dampness and mold, but the findings are not as robust as those in offices. In particular, most studies included a small number of buildings, so there is a substantial chance that building factors other than dampness and mold that differed among the damp and dry schools could have caused the reported differences in health outcomes. In addition, multivariate regression modeling is less likely to adequately control for confounding building factors with only a small number of buildings. A second major weakness is that many studies had a small number of subjects leading to poor statistical power for detecting increased health risks among occupants of damp and moldy schools.
Despite these weaknesses, the overall results indicate that adverse health outcomes are likely to be elevated among occupants of damp and moldy schools. Many of the studies found that damp or moldy schools, or molds and bacteria in floor dust were significant risk factors for a variety of health outcomes. Only one study reported an inverse finding of improved health with dampness or mold. While the extent to which the studies controlled for confounding varied greatly, studies that controlled for numerous potential confounders still found statistically significant health risks. Taken in isolation, the schools literature is non-conclusive. However, the consistency of findings from these school-based studies with the findings from homes, offices, and other buildings strengthens the case for adverse health effects in damp and moldy schools.
POLICY AND PROGRAM CONSIDERATIONS
Excess moisture in a building can result from a number of potential failures in the design, construction, maintenance and occupancy of buildings. There is a public interest in changing behaviors and practices in the building community that lead to these failures, and in mitigating problems when they do occur.
CONCLUSION
Effective moisture control in buildings supports public health. There is general consensus in the scientific community that exposure to dampness and mold substantially increases the risk of a variety of health effects, most notably those associated with the respiratory system. The increased risk to exposed individuals combined with the relatively high prevalence of dampness and mold in buildings means that large numbers of individuals are adversely impacted. In this paper, we estimated that approximately 4.6 million cases of asthma in the U.S. result from exposure to dampness and mold and that the resulting economic cost of this health impact is approximately $3.5 billion annually. Public policies and programs can reduce these impacts by both preventing moisture and mold problems in buildings and mitigating them when they do occur. * Only about 5% of the population test as allergic to molds using standard mold extracts. This study shows: a) a high portion of occupants can become allergic to the specific indoor molds they are exposed to, suggesting that the prevalence of allergy to molds may be much higher than often reported. Key to table: assoc. = associated; CFU = colony forming units; CI = 95% confidence interval; conc. = concentration; CO = conc. of carbon monoxide in indoor air; CO2 = conc. of carbon dioxide in indoor air; CS = cross sectional; Dx. or dx. = diagnosis; NO2 = nitrogen dioxide conc.; OR = odds ratio; RH = relative humidity; RSP = airborne conc. of respirable particles; signif. = significantly (p<0.05); spirometry =one or more lung function outcomes measured via spirometry; Stratified CS = a study that intentionally selects damp and dry buildings; Sx. = symptoms determined via questionnaire; T = air temperature indoors; TVOC = total airborne volatile organic compound conc.; vent. = ventilation In groups with highest vs. lowest fungal concentrations in floor dust, significant increases found for lower respiratory (OR 1.7, CI 1.02-2.77 to OR 2.4, CI 1.29-4.59); throat irritation (OR 1.7, CI 1.06-2.82); rash/itchy skin (OR 3.0, ). Exposure-response relationships were generally linear. However, endotoxin increased associations of fungi on respiratory symptoms, i.e, presence of both was associated with greater increase than their added individual effects. Suggests how moisture might correlate with an effect size not directly associated with specific moisture-associated exposures. Key to table: assoc. = associated; CFU = colony forming units; CI = 95% confidence interval; conc. = concentration; CO = conc. of carbon monoxide in indoor air; CO2 = conc. of carbon dioxide in indoor air; CS = cross sectional; Dx. or dx. = diagnosis; NO2 = nitrogen dioxide conc.; OR = odds ratio; RH = relative humidity; RSP = airborne conc. of respirable particles; signif. = significantly (p<0.05); spirometry =one or more lung function outcomes measured via spirometry; Stratified CS = a study that intentionally selects damp and dry buildings; Sx. = symptoms determined via questionnaire; T = air temperature indoors; TVOC = total airborne volatile organic compound conc.; vent. = ventilation Operation of ultraviolet germicidal system associated with significant reduction in Sx as follows: Any Sx (OR 0.8, CI 0.7 -0.99) Mucosal Sx (OR 0.7, CI 0.6 -0.9) Respiratory Sx (OR 0.6, CI 0.4 -0.9) Musculoskeletal Sx (OR 0.8, CI 0.6 -1.1) [increased susc in atopics] 
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